These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 727132)

  • 21. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
    Croft CH; Kennelly BM
    S Afr Med J; 1981 Jun; 59(24):871-3. PubMed ID: 7233313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disopyramide-induced Torsade de Pointes.
    Tzivoni D; Keren A; Stern S; Gottlieb S
    Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    Lerman BB; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse reaction to disopyramide.
    Dibble JB; Webster NR
    Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of oral disopyramide phosphate on induction and sustenance of atrioventricular reentrant tachycardia incorporating retrograde accessory pathway conduction.
    Kou HC; Hung JS; Lee YS; Wu D
    Circulation; 1982 Aug; 66(2):454-62. PubMed ID: 6807567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extreme tachycardia complicating the use of disopyramide in atrial flutter.
    Robertson CE; Miller HC
    Br Heart J; 1980 Nov; 44(5):602-3. PubMed ID: 7437205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
    Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
    Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paradoxic response to disopyramide and quinidine (author's transl)].
    Breithardt G; Seipel L; Haerten K
    Z Kardiol; 1980 Aug; 69(8):556-61. PubMed ID: 7445656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some cardiovascular problems with disopyramide.
    Warrington SJ; Hamer J
    Postgrad Med J; 1980 Apr; 56(654):229-33. PubMed ID: 7433320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.
    Swiryn S; Bauernfeind RA; Strasberg B; Palileo E; Iverson N; Levy PS; Rosen KM
    Am Heart J; 1982 Jul; 104(1):43-50. PubMed ID: 7090985
    [No Abstract]   [Full Text] [Related]  

  • 31. Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
    Riccioni N; Castiglioni M; Bartolomei C
    Am Heart J; 1983 May; 105(5):870-1. PubMed ID: 6846134
    [No Abstract]   [Full Text] [Related]  

  • 32. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
    Griffith MJ; Linker NJ; Garratt CJ; Ward DE; Camm AJ
    Lancet; 1990 Sep; 336(8716):670-3. PubMed ID: 1975861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
    Benditt DG; Pritchett EL; Wallace AG; Gallagher JJ
    Eur J Cardiol; 1979 Apr; 9(4):255-76. PubMed ID: 428417
    [No Abstract]   [Full Text] [Related]  

  • 34. Disopyramide.
    Morady F; Scheinman MM; Desai J
    Ann Intern Med; 1982 Mar; 96(3):337-43. PubMed ID: 7036817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
    Acta Cardiol; 1974; Suppl 18():441-58. PubMed ID: 4138236
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
    Camm J; Ward D; Washington HG; Spurrell RA
    Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hirosawa K
    Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Danger of use of disopyramide in patients with hypertrophic obstructive cardiomyopathy. An electrophysiologic study.
    Miyajima S; Aizawa Y; Matsuoka A; Okabe M; Shibata A
    Jpn Heart J; 1988 Jan; 29(1):115-9. PubMed ID: 3398239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological therapy and prevention of recurrent ventricular tachycardia].
    Vajola SF; Chiavarelli V; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1743-9. PubMed ID: 7343378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.